Real Time Polymerase Chain Reaction (qPCR) Market Poised for Remarkable Growth by 2030

Introduction:

Real-Time Polymerase Chain Reaction (qPCR) has emerged as a revolutionary technique in molecular biology, transforming the landscape of genetic analysis and diagnostics. The qPCR market has witnessed significant growth in recent years, driven by technological advancements, increasing applications in research, and the growing demand for precision in the field of life sciences.

Market Overview:

The global Real Time Polymerase Chain Reaction (qPCR) market size was USD 4.64 Billion in 2021 and is expected to register a revenue CAGR of 7.8% during the forecast period. Increasing incidence of chronic disorders, such as Human Immunodeficiency Virus (HIV), malaria, hepatitis, and cancer and significant technological advancements in qPCR devices that provide high performance and are more efficient, are major factors driving market revenue growth. According to World Health Organization (WHO), nearly 10 million deaths were accounted for in 2020. About 30% of cancer cases in low- and lower-middle-income countries are caused by cancer-causing diseases such as Human Papillomavirus (HPV) and hepatitis. Cancer is among the leading cause of death worldwide, while breast cancer is the most prevalent type of cancer with 290,560 new cases anticipated in the U.S. in 2022.

Real time Polymerase Chain Reaction (qPCR) a technique used to monitor the progress of a PCR reaction in real-time. It is also known as a quantitative polymerase chain reaction (qPCR), which is a laboratory technique of molecular biology based on Polymerase Chain Reaction (PCR). Recent technological advancements in Real Time Polymerase Chain Reaction (qPCR) devices are also driving market revenue growth. For instance, on 9 February 2022, New England Biolabs (NEB), a U.S.-based production and discovery of enzymes for molecular biology applications announced to release ,its first lyophilized product manufactured by Fluorogenics which is LyoPrime Luna Probe One-Step RT-qPCR Mix with Uracil-DNA Dlycosylase (UDG). This lyophilized master mix allows for sensitive, linear real-time detection of target Ribonucleic Acid (RNA) sequences in a format that is stable at room temperature while displaying same robust characteristics and performance as previously published liquid 4X mix.

Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @

Key Drivers:

Rising Prevalence of Chronic Diseases: qPCR technology plays a pivotal role in the diagnosis and monitoring of various chronic diseases such as cancer, cardiovascular disorders, and infectious diseases. The increasing global burden of these conditions is driving the demand for accurate and efficient diagnostic tools, thereby fueling the growth of the qPCR market.
Technological Advancements: Continuous innovation in qPCR technologies has resulted in enhanced sensitivity, specificity, and speed of analysis. The integration of advanced features such as automation, multiplexing, and high-throughput capabilities has expanded the utility of qPCR in various applications, including genotyping, gene expression analysis, and pathogen detection.
Expanding Applications in Research: The versatility of qPCR has led to its widespread adoption in both academic and industrial research settings. Researchers utilize qPCR for gene expression profiling, SNP genotyping, and the quantification of nucleic acids. The ease of use and reliability of qPCR make it an indispensable tool in molecular biology laboratories worldwide.
Growing Investment in Life Sciences Research: Increasing funding for life sciences research and the emphasis on personalized medicine have bolstered the demand for advanced molecular diagnostic tools. qPCR’s ability to provide real-time and quantitative results has positioned it as a preferred choice for researchers and clinicians alike.

Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/5500

Challenges and Opportunities:

High Instrumentation Costs: The initial capital investment required for qPCR instruments can be a significant barrier for smaller laboratories or research facilities. However, efforts are underway to develop more cost-effective instruments, providing opportunities for market players to cater to a broader customer base.
Standardization and Data Interpretation: Standardizing qPCR protocols and ensuring the accurate interpretation of data remain challenges in the field. Collaborative efforts by industry stakeholders and regulatory bodies are essential to establish standardized practices, fostering trust in qPCR results across different laboratories.
Emerging Markets: The qPCR market presents significant growth opportunities in emerging economies. Increased awareness about molecular diagnostics, coupled with rising healthcare infrastructure investments, is expected to drive market expansion in regions such as Asia-Pacific and Latin America.

Market Segmentation:

The qPCR market can be segmented based on product type, application, end-user, and region. Key product categories include instruments, reagents, and consumables. Applications span across research, diagnostics, forensics, and others. Academic and research institutions, pharmaceutical and biotechnology companies, and clinical diagnostics laboratories are major end-users.

Some recent developments are as follows:

On 29 July 2022, Transgen Biotech Co., a manufacturer of molecular and cellular biology products based in Beijing, China announced to launch DV106 Monkeypox Virus (MPXV) Nucleic Acid qPCR Detection Kit. This kit is used to detect MPXV in clinical samples including blood, skin lesions, exudates, saliva, urine, nasal swabs, oropharyngeal swabs, saliva, and other clinical samples from probable cases of Monkeypox Virus (MPXV) infection.
On 10 May 2022, Cipla Inc. in collaboration with Genes2Me Pvt. Ltd. announced to launch “RT-Direct” multiplex COVID-19 RT PCR Test kit in India. The Indian Council of Medical Research (ICMR)-approved Center validated this kit. It is based on the “gold standard RT-PCR method” and covers three target genes that are unique to SARS-COV-2 virus together with an Integrated Circuit (IC), making it significantly more sophisticated than methods that just cover one or two target genes. As a result, the RTPCR test’s sensitivity is significantly increased.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/5500

Conclusion:

The Real-Time Polymerase Chain Reaction (qPCR) market is poised for continued growth, driven by technological advancements, increasing research activities, and the rising demand for precision diagnostics. As the industry addresses challenges and embraces opportunities, qPCR is likely to remain a cornerstone in molecular biology, contributing significantly to advancements in healthcare and life sciences.

Explore additional Reports:

First Aid Kit Market @ https://www.reportsanddata.com/report-detail/first-aid-kit-market

Maggot Debridement Therapy Market @ https://www.reportsanddata.com/report-detail/maggot-debridement-therapy-market

Mesenchymal Stem Cells Market @ https://www.reportsanddata.com/report-detail/mesenchymal-stem-cells-market

Nuclear Medicines Market @ https://www.reportsanddata.com/report-detail/nuclear-medicines-market

Single Use Bioprocessing Market @ https://www.reportsanddata.com/report-detail/single-use-bioprocessing-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report